Bank of New York Mellon Corp - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$236,927
-37.1%
103,012
-0.1%
0.00%
Q2 2023$376,512
+395.4%
103,154
+384.6%
0.00%
Q1 2023$75,995
+25.3%
21,2870.0%0.00%
Q4 2022$60,668
+26.4%
21,287
-0.2%
0.00%
Q3 2022$48,000
-9.4%
21,329
-0.0%
0.00%
Q2 2022$53,000
-90.1%
21,339
-80.5%
0.00%
Q1 2022$533,000
-55.8%
109,168
+2.3%
0.00%
Q4 2021$1,207,000
-22.7%
106,738
-0.4%
0.00%
Q3 2021$1,561,000
+33.3%
107,136
+6.5%
0.00%
Q2 2021$1,171,000
-12.7%
100,578
-8.6%
0.00%
Q1 2021$1,342,000
-6.7%
110,020
-4.3%
0.00%
Q4 2020$1,438,000
-14.1%
114,946
+3.3%
0.00%
Q3 2020$1,675,000
-38.6%
111,315
-0.1%
0.00%
-100.0%
Q2 2020$2,730,000
+158.5%
111,390
+49.7%
0.00%
Q1 2020$1,056,000
+0.4%
74,419
+12.3%
0.00%
Q4 2019$1,052,000
+122.4%
66,282
+18.2%
0.00%
Q3 2019$473,000
-6.3%
56,099
-0.2%
0.00%
Q2 2019$505,000
+16.6%
56,191
+0.3%
0.00%
Q1 2019$433,000
+78.2%
56,040
+8.2%
0.00%
Q4 2018$243,000
-39.7%
51,776
+16.3%
0.00%
Q3 2018$403,000
-23.5%
44,504
-0.0%
0.00%
Q2 2018$527,000
+68.4%
44,505
+99.8%
0.00%
Q1 2018$313,00022,2760.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 1,510,282$7,370,0004.76%
SANDERS MORRIS HARRIS LLC 873,021$4,261,0000.83%
P.A.W. CAPITAL CORP 150,000$732,0000.76%
Nantahala Capital Management 2,244,359$10,952,0000.48%
Bleichroeder LP 552,000$2,694,0000.48%
APOGEM CAPITAL LLC 111,259$543,0000.37%
Slate Path Capital LP 1,483,619$7,240,0000.37%
Robertson Stephens Wealth Management, LLC 478,500$2,335,0000.20%
CARLSON CAPITAL L P 405,000$1,976,0000.14%
Bridgefront Capital, LLC 19,968$97,0000.12%
View complete list of CUE BIOPHARMA INC shareholders